Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.
about
Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysisPhosphorylation and activation of androgen receptor by Aurora-AA Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches.Phosphorylation of NuMA by Aurora-A kinase in PC-3 prostate cancer cells affects proliferation, survival, and interphase NuMA localization.The expression of AURKA is androgen regulated in castration-resistant prostate cancer.
P2860
Persistent expression of Aurora-A after neoadjuvant hormonal therapy as a predictor of a poor clinical outcome in patients undergoing radical prostatectomy for prostate cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Persistent expression of Auror ...... tatectomy for prostate cancer.
@en
Persistent expression of Auror ...... tatectomy for prostate cancer.
@nl
type
label
Persistent expression of Auror ...... tatectomy for prostate cancer.
@en
Persistent expression of Auror ...... tatectomy for prostate cancer.
@nl
prefLabel
Persistent expression of Auror ...... tatectomy for prostate cancer.
@en
Persistent expression of Auror ...... tatectomy for prostate cancer.
@nl
P2093
P2860
P1433
P1476
Persistent expression of Auror ...... tatectomy for prostate cancer.
@en
P2093
Atsushi Takenaka
Hideaki Miyake
Junya Furukawa
Masato Fujisawa
P2860
P304
P356
10.1111/J.1464-410X.2007.06982.X
P577
2007-05-19T00:00:00Z